Rothschild Asset Management Inc. raised its holdings in Cooper Companies Inc (NYSE:COO) by 8.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 126,611 shares of the medical device company’s stock after purchasing an additional 9,712 shares during the quarter. Rothschild Asset Management Inc. owned 0.26% of Cooper Companies worth $30,021,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Cooper Companies by 3.3% in the 2nd quarter. Vanguard Group Inc. now owns 4,938,181 shares of the medical device company’s stock worth $1,182,298,000 after acquiring an additional 156,449 shares in the last quarter. BlackRock Inc. increased its position in Cooper Companies by 4.5% in the 2nd quarter. BlackRock Inc. now owns 3,210,032 shares of the medical device company’s stock valued at $768,546,000 after buying an additional 138,395 shares in the last quarter. Janus Henderson Group PLC increased its position in Cooper Companies by 558.5% in the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after buying an additional 1,845,368 shares in the last quarter. Pioneer Investment Management Inc. boosted its stake in Cooper Companies by 136.6% during the 2nd quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock valued at $293,589,000 after purchasing an additional 708,028 shares during the last quarter. Finally, Bessemer Group Inc. boosted its stake in Cooper Companies by 39.1% during the 2nd quarter. Bessemer Group Inc. now owns 575,951 shares of the medical device company’s stock valued at $137,895,000 after purchasing an additional 161,772 shares during the last quarter. 96.79% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by corporate insiders.
A number of research firms have issued reports on COO. Jefferies Group reiterated a “buy” rating and set a $250.00 price target on shares of Cooper Companies in a research note on Tuesday, September 12th. Stephens reiterated an “equal weight” rating and set a $250.00 price target (up previously from $235.00) on shares of Cooper Companies in a research note on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 price objective on the stock in a research note on Tuesday, October 10th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a research note on Monday, August 28th. Finally, Piper Jaffray Companies boosted their target price on shares of Cooper Companies from $265.00 to $280.00 and gave the company an “overweight” rating in a report on Friday, September 1st. Six research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $260.70.
Cooper Companies Inc (NYSE COO) traded up $4.73 during midday trading on Thursday, reaching $238.80. 660,617 shares of the company’s stock traded hands, compared to its average volume of 422,476. The company has a current ratio of 2.51, a quick ratio of 1.29 and a debt-to-equity ratio of 0.38. Cooper Companies Inc has a twelve month low of $165.98 and a twelve month high of $256.39. The stock has a market capitalization of $11,350.84, a price-to-earnings ratio of 24.80, a price-to-earnings-growth ratio of 1.94 and a beta of 0.54.
Cooper Companies (NYSE:COO) last posted its earnings results on Wednesday, December 6th. The medical device company reported $2.65 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.66 by ($0.01). Cooper Companies had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. During the same quarter in the prior year, the company posted $2.28 earnings per share. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. equities analysts expect that Cooper Companies Inc will post 9.72 earnings per share for the current year.
WARNING: “Rothschild Asset Management Inc. Raises Position in Cooper Companies Inc (COO)” was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2017/12/07/cooper-companies-inc-the-coo-shares-bought-by-rothschild-asset-management-inc-updated-updated.html.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.